{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:00:37Z","timestamp":1776394837168,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00210-025-04916-z","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:27:19Z","timestamp":1766989639000},"page":"8395-8411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design and characterization of phloretin-loaded PEG\u2013lipid hybrid micelles for enhanced breast cancer therapy"],"prefix":"10.1007","volume":"399","author":[{"given":"Imran","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shazia","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"12","key":"4916_CR1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/pharmaceutics12121212","volume":"12","author":"S Alven","year":"2020","unstructured":"Alven S, Aderibigbe BA (2020) The therapeutic efficacy of dendrimer and micelle formulations for breast cancer treatment. Pharmaceutics 12(12):1212","journal-title":"Pharmaceutics"},{"issue":"4","key":"4916_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1872210515666210720125717","volume":"16","author":"R Aqeel","year":"2022","unstructured":"Aqeel R, Srivastava N, Kushwaha P (2022) Micelles in cancer therapy: an update on preclinical and clinical status. Recent Pat Nanotechnol 16(4):283\u2013294. https:\/\/doi.org\/10.2174\/1872210515666210720125717","journal-title":"Recent Pat Nanotechnol"},{"key":"4916_CR3","doi-asserted-by":"publisher","unstructured":"Bhattacharya S, Saoji SD (2024) Development, optimization, and characterization of polymeric micelles to improve dasatinib oral bioavailability: Hep G2 cell cytotoxicity and in vivo pharmacokinetics for targeted liver cancer therapy. Heliyon 10(21): e39632.https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39632","DOI":"10.1016\/j.heliyon.2024.e39632"},{"issue":"3","key":"4916_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.7150\/ijbs.85443","volume":"20","author":"TM Chang","year":"2024","unstructured":"Chang TM, Chi MC, Chiang YC, Lin CM, Fang ML, Lee CW, Liu JF, Kou YR (2024) Promotion of ROS-mediated apoptosis, G2\/M arrest, and autophagy by naringenin in non-small cell lung cancer. Int J Biol Sci 20(3):1093","journal-title":"Int J Biol Sci"},{"issue":"10","key":"4916_CR5","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","volume":"28","author":"AS Choudhari","year":"2020","unstructured":"Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O (2020) Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol 28(10):1614","journal-title":"Front Pharmacol"},{"issue":"22","key":"4916_CR6","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1021\/acs.jpcb.1c00893","volume":"125","author":"A Del Regno","year":"2021","unstructured":"Del Regno A, Warren PB, Bray DJ, Anderson RL (2021) Critical micelle concentrations in surfactant mixtures and blends by simulation. J Phys Chem B 125(22):5983\u20135990","journal-title":"J Phys Chem B"},{"issue":"1","key":"4916_CR7","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.52711\/0974-360X.2022.00576","volume":"15","author":"R Devi","year":"2022","unstructured":"Devi R, Komala M, Jayanthi B (2022) Studies on drug compatibility with different pharmaceutical excipients in nanoparticle formulation. Res J Pharm Technol 15(1):3443\u20133446. https:\/\/doi.org\/10.52711\/0974-360X.2022.00576","journal-title":"Res J Pharm Technol"},{"issue":"3","key":"4916_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s10555-023-10119-w","volume":"42","author":"S Fakhri","year":"2023","unstructured":"Fakhri S, Moradi SZ, Faraji F, Farhadi T, Hesami O, Iranpanah A, Webber K, Bishayee A (2023) Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance. Cancer Metastasis Rev 42(3):959\u20131020","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"4916_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17020173","volume":"17","author":"Z Hu","year":"2025","unstructured":"Hu Z, Bousbaa H (2025) Recent advances in anticancer strategies. Cancers (Basel) 17(2):173. https:\/\/doi.org\/10.3390\/cancers17020173","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4916_CR10","volume":"2017","author":"Z Huyut","year":"2017","unstructured":"Huyut Z, Beydemir \u015e, G\u00fcl\u00e7in \u0130 (2017) Antioxidant and antiradical properties of selected flavonoids and phenolic compounds. Biochem Res Int 2017(1):7616791","journal-title":"Biochem Res Int"},{"key":"4916_CR11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jconrel.2020.07.003","volume":"326","author":"V Jain","year":"2020","unstructured":"Jain V, Kumar H, Anod HV, Chand P, Gupta NV, Dey S, Kesharwani SS (2020) A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. J Control Release 326:628\u2013647. https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.003","journal-title":"J Control Release"},{"issue":"6","key":"4916_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-018-0547-8","volume":"19","author":"S Jasra","year":"2018","unstructured":"Jasra S, Anampa J (2018) Anthracycline use for early stage breast cancer in the modern era: a review. Curr Treat Options Oncol 19(6):30","journal-title":"Curr Treat Options Oncol"},{"key":"4916_CR13","doi-asserted-by":"crossref","unstructured":"Kapoor DU, Goyal R, Kukkar RR, Gautam RK (2023) Recent advancement of nanotherapeutics to treat breast cancer. Drug and Therapy Development for Triple Negative Breast Cancer 23:65\u201383","DOI":"10.1002\/9783527841165.ch3"},{"issue":"1","key":"4916_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.5530\/ctbp.2023.1.7","volume":"17","author":"M Keerthana","year":"2023","unstructured":"Keerthana M, Komala G, Nagaraju R (2023) Polymeric micelles of oregano-formulation and in-vitro evaluation. Curr Trends Biotechnol Pharm 17(1):660\u2013670","journal-title":"Curr Trends Biotechnol Pharm"},{"key":"4916_CR15","doi-asserted-by":"publisher","DOI":"10.12912\/27197050\/169935","author":"A Labhar","year":"2023","unstructured":"Labhar A, Benamari O, El-Mernissi Y, Salhi A, Ahari M, El Barkany S, Amhamdi H (2023) Phytochemical, anti-inflammatory and antioxidant activities of Pistacia lentiscus L. leaves from Ajdir, Al Hoceima Province, Morocco. Ecol Eng Environm Technology. https:\/\/doi.org\/10.12912\/27197050\/169935","journal-title":"Ecol Eng Environm Technology"},{"key":"4916_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.940239","volume":"12","author":"JI Lai","year":"2022","unstructured":"Lai JI, Chao TC, Liu CY, Huang CC, Tseng LM (2022) A systemic review of taxanes and their side effects in metastatic breast cancer. Front Oncol 12:940239","journal-title":"Front Oncol"},{"issue":"11","key":"4916_CR17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Zhou J, Wei W (2021) Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun Lond 41(11):1183\u20131194. https:\/\/doi.org\/10.1002\/cac2.12207","journal-title":"Cancer Commun Lond"},{"issue":"7","key":"4916_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1080\/1061186X.2025.2469753","volume":"33","author":"J Li","year":"2025","unstructured":"Li J, Li T, Gong M, Wang X, Hua Q, Jiang X, Wang Q, Toreniyazov E, Yu J, Cao X, Adu-Frimpong M, Xu X (2025) Preparation, in vitro and in vivo evaluation of phloretin-loaded TPGS\/Pluronic F68 modified mixed micelles with enhanced bioavailability and anti-ageing activity. J Drug Target 33(7):1167\u20131178","journal-title":"J Drug Target"},{"issue":"12","key":"4916_CR19","first-page":"1622597","volume":"13","author":"H Liu","year":"2025","unstructured":"Liu H (2025) Functional foods and exercise in breast cancer: epigenetic modulation, chemotherapy tolerance, and fatigue management. Front Nutr 13(12):1622597","journal-title":"Front Nutr"},{"issue":"1","key":"4916_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111149","volume":"194","author":"HS Mahajan","year":"2020","unstructured":"Mahajan HS, Patil PH (2020) Central composite design-based optimization of lopinavir vitamin E-TPGS micelle: in vitro characterization and in vivo pharmacokinetic study. Colloids Surf B Biointerfaces 194(1):111149","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"10","key":"4916_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.4155\/tde-2020-0008","volume":"11","author":"N Majumder","year":"2020","unstructured":"Majumder N, G Das N, Das SK (2020) Polymeric micelles for anticancer drug delivery. Ther Deliv 11(10):613\u2013635. https:\/\/doi.org\/10.4155\/tde-2020-0008","journal-title":"Ther Deliv"},{"issue":"6","key":"4916_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17062078","volume":"17","author":"MA Medina","year":"2020","unstructured":"Medina MA, Oza G, Sharma A, Arriaga LG, Hern\u00e1ndez Hern\u00e1ndez JM, Rotello VM, Ramirez JT (2020) Triple-negative breast cancer: a review of conventional and advanced therapeutic strategies. Int J Environ Res Public Health 17(6):2078. https:\/\/doi.org\/10.3390\/ijerph17062078","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"4916_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/antiox10040512","volume":"10","author":"L Minsat","year":"2021","unstructured":"Minsat L, Peyrot C, Brunissen F, Renault JH, Allais F (2021) Synthesis of biobased phloretin analogues: an access to antioxidant and anti-tyrosinase compounds for cosmetic applications. Antioxidants (Basel) 10(4):512. https:\/\/doi.org\/10.3390\/antiox10040512","journal-title":"Antioxidants (Basel)"},{"issue":"11","key":"4916_CR24","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1021\/acs.jpcb.1c09685","volume":"126","author":"IK Mkam Tsengam","year":"2022","unstructured":"Mkam Tsengam IK, Omarova M, Kelley EG, McCormick A, Bothun GD, Raghavan SR, John VT (2022) Transformation of lipid vesicles into micelles by adding nonionic surfactants: elucidating the structural pathway and the intermediate structures. J Phys Chem B 126(11):2208\u20132216","journal-title":"J Phys Chem B"},{"issue":"17","key":"4916_CR25","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.3390\/nu14173638","volume":"14","author":"KT Nakhate","year":"2022","unstructured":"Nakhate KT, Badwaik H, Choudhary R, Sakure K, Agrawal YO, Sharma C, Ojha S, Goyal SN (2022) Therapeutic potential and pharmaceutical development of a multitargeted flavonoid phloretin. Nutrients 14(17):3638. https:\/\/doi.org\/10.3390\/nu14173638","journal-title":"Nutrients"},{"issue":"4","key":"4916_CR26","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s13346-023-01443-3","volume":"14","author":"M Nasr","year":"2024","unstructured":"Nasr M, Hashem F, Teiama M, Tantawy N, Abdelmoniem R (2024) Folic acid grafted mixed polymeric micelles as a targeted delivery strategy for tamoxifen citrate in treatment of breast cancer. Drug Deliv Transl Res 14(4):945\u2013958","journal-title":"Drug Deliv Transl Res"},{"issue":"194","key":"4916_CR27","doi-asserted-by":"publisher","first-page":"114724","DOI":"10.1016\/j.addr.2023.114724","volume":"1","author":"C Pacheco","year":"2023","unstructured":"Pacheco C, Baiao A, Ding T, Cui W, Sarmento B (2023) Recent advances in long-acting drug delivery systems for anticancer drug. Adv Drug Deliv Rev 1(194):114724","journal-title":"Adv Drug Deliv Rev"},{"key":"4916_CR28","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.2147\/IJN.S15309","volume":"13","author":"A Patra","year":"2018","unstructured":"Patra A, Satpathy S, Shenoy AK, Bush JA, Kazi M, Hussain MD (2018) Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers. Int J Nanomedicine 13:2869\u20132881. https:\/\/doi.org\/10.2147\/IJN.S15309","journal-title":"Int J Nanomedicine"},{"issue":"22","key":"4916_CR29","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.3390\/molecules25184330","volume":"25","author":"N Ruwizhi","year":"2020","unstructured":"Ruwizhi N, Aderibigbe BA (2020) The efficacy of cholesterol-based carriers in drug delivery. Molecules 25(22):4330. https:\/\/doi.org\/10.3390\/molecules25184330","journal-title":"Molecules"},{"issue":"1","key":"4916_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/1735-5362.263554","volume":"14","author":"A Salimi","year":"2019","unstructured":"Salimi A, Zadeh BS, Kazemi M (2019) Preparation and optimization of polymeric micelles as an oral drug delivery system for deferoxamine mesylate: in vitro: and: ex vivo: studies. Res Pharm Sci 14(1):293\u2013307. https:\/\/doi.org\/10.4103\/1735-5362.263554","journal-title":"Res Pharm Sci"},{"key":"4916_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-030-20301-6_8","volume":"28","author":"M Sambi","year":"2019","unstructured":"Sambi M, Qorri B, Harless W, Szewczuk MR (2019) Therapeutic options for metastatic breast cancer. Breast Cancer Metastasis and Drug Resistance: Challenges and Progress 28:131\u2013172","journal-title":"Breast Cancer Metastasis and Drug Resistance: Challenges and Progress"},{"key":"4916_CR32","doi-asserted-by":"publisher","unstructured":"Santhanakrishnan KR, Koilpillai J, Narayanasamy D, Santhanakrishnan K (2024) PEGylation in pharmaceutical development: current status and emerging trends in macromolecular and immunotherapeutic drugs. Cureus 16(8). https:\/\/doi.org\/10.7759\/cureus.66669","DOI":"10.7759\/cureus.66669"},{"issue":"46","key":"4916_CR33","doi-asserted-by":"publisher","first-page":"100570","DOI":"10.1016\/j.colcom.2021.100570","volume":"1","author":"S Shah","year":"2022","unstructured":"Shah S, Famta P, Raghuvanshi RS, Singh SB, Srivastava S (2022) Lipid polymer hybrid nanocarriers: insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications. Colloid and Interface Science Communications 1(46):100570","journal-title":"Colloid and Interface Science Communications"},{"key":"4916_CR34","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4916_CR35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1039\/C7RA07796C","volume":"8","author":"D Tang","year":"2018","unstructured":"Tang D, Zhao X, Yang T, Wang C (2018) Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy. RSC Adv 8(1):380\u2013399","journal-title":"RSC Adv"},{"issue":"3","key":"4916_CR36","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/ijms24032643","volume":"24","author":"S Wang","year":"2023","unstructured":"Wang S, Chen Y, Guo J, Huang Q (2023) Liposomes for tumor targeted therapy: a review. Int J Mol Sci 24(3):2643. https:\/\/doi.org\/10.3390\/ijms24032643","journal-title":"Int J Mol Sci"},{"issue":"19","key":"4916_CR37","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.3390\/molecules28196790","volume":"28","author":"J Wang","year":"2023","unstructured":"Wang J, Zhao Y, Zhai B, Cheng J, Sun J, Zhang X, Guo D (2023) Phloretin transfersomes for transdermal delivery: design, optimization, and in vivo evaluation. Molecules 28(19):6790. https:\/\/doi.org\/10.3390\/molecules28196790","journal-title":"Molecules"},{"issue":"1130","key":"4916_CR38","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson L, Gathani T (2022) Understanding breast cancer as a global health concern. Br J Radiol 95(1130):20211033. https:\/\/doi.org\/10.1259\/bjr.20211033","journal-title":"Br J Radiol"},{"issue":"16","key":"4916_CR39","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.3390\/jcm13164610","volume":"13","author":"MC Winkler","year":"2024","unstructured":"Winkler MC, Hetjens S (2024) Risk factors and preventive measures for breast cancer. J Clin Med 13(16):4610","journal-title":"J Clin Med"},{"issue":"9","key":"4916_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10050570","volume":"10","author":"A Wosiak","year":"2023","unstructured":"Wosiak A, Szmajda-Krygier D, Pietrzak J, Boncela J, Balcerczak E (2023) Assessment of the influence of 5-fluorouracil on SMAD4 and TGFB1 gene expression, apoptosis induction and DNA damage in human cell lines. Bioengineering 10(9):570. https:\/\/doi.org\/10.3390\/bioengineering10050570","journal-title":"Bioengineering"},{"key":"4916_CR41","doi-asserted-by":"crossref","unstructured":"Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A (2020). Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci 7:193\u2013198","DOI":"10.3389\/fmolb.2020.00193"},{"key":"4916_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110809","volume":"132","author":"YY Zhao","year":"2020","unstructured":"Zhao YY, Fan Y, Wang M, Wang J, Cheng JX, Zou JB, Zhang XF, Shi YJ, Guo DY (2020) Studies on pharmacokinetic properties and absorption mechanism of phloretin: in vivo and in vitro. Biomed Pharmacother 132:110809. https:\/\/doi.org\/10.1016\/j.biopha.2020.110809","journal-title":"Biomed Pharmacother"},{"key":"4916_CR43","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.2147\/IJN.S158696","volume":"13","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Zhang L, Yang T, Wu H (2018) Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomedicine 13:2921\u20132942. https:\/\/doi.org\/10.2147\/IJN.S158696","journal-title":"Int J Nanomedicine"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04916-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04916-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04916-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:37:42Z","timestamp":1776393462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04916-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4916"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04916-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}